Nadia Al‐Fakhri

1.8k citations

26 papers · 1.4k indexed · h-index 15

Co-authors: Klaus T. Preissner Triantafyllos Chavakis Peter P. Nawroth Michael Schoppet John Morser Thomas Linn Mariko Nagashima Steffen Witte
Topics: Cell Adhesion Molecules Research (10 papers)Protease and Inhibitor Mechanisms (5 papers)Bone Metabolism and Diseases (5 papers)
Cited by: Clinical Biochemistry Immunology and Allergy Immunology
Journals: The Journal of Experimental Medicine The Journal of Immunology The Journal of Clinical Endocrinology & Metabolism
Partner nations: Germany United States Australia

In The Last Decade

Nadia Al‐Fakhri

26 papers receiving 1.4k citations

Peers

Countries citing papers authored by Nadia Al‐Fakhri

Since Specialization

Citations

This map shows the geographic impact of Nadia Al‐Fakhri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Al‐Fakhri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Al‐Fakhri more than expected).

Fields of papers citing papers by Nadia Al‐Fakhri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Al‐Fakhri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Al‐Fakhri. The network helps show where Nadia Al‐Fakhri may publish in the future.

Co-authorship network of co-authors of Nadia Al‐Fakhri

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Al‐Fakhri. A scholar is included among the top collaborators of Nadia Al‐Fakhri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Al‐Fakhri. Nadia Al‐Fakhri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Monocytic expression of osteoclast-associated receptor (OSCAR) is induced in atherosclerotic mice and regulated by oxidized low-density lipoprotein in vitro 2013 ·Biochemical and Biophysical Research Communications ·Kathrin Sinningen,Martina Rauner,Claudia Goettsch,Nadia Al‐Fakhri,Michael Schoppet,Lorenz C. Hofbauer	11
2	Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis 2013 ·Neurobiology of Disease ·(unknown),(unknown),(unknown),Peter Reuter,(unknown),Ralf Kinscherf,Max Gassmann,Tibo Gerriets,Nadia Al‐Fakhri	7
3	Pituitary Function in Patients with Hereditary Haemochromatosis 2012 ·Hormone and Metabolic Research ·(unknown),(unknown),Stephan Schaefer,Nadia Al‐Fakhri,P. Kann	5
4	Analytical performance of a multiplexed, bead-based cytokine detection system in small volume samples 2011 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown),(unknown),Marjut Roponen,Roger Lauener,Harald Renz,Petra Ina Pfefferle,Nadia Al‐Fakhri	13
5	Vascular endothelial growth factor confers endothelial resistance to apoptosis through poly(ADP‐ribose) polymerase 2011 ·Journal of Thrombosis and Haemostasis ·(unknown),(unknown),(unknown),(unknown),(unknown),Martin Heidt,(unknown),Nadia Al‐Fakhri	2
6	Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (TRAIL) levels in malignant and benign pericardial effusions 2011 ·Clinical Biochemistry ·Konstantinos Karatolios,Sabine Pankuweit,Claudia Goettsch,Lorenz C. Hofbauer,Nina Timmesfeld,Nadia Al‐Fakhri,Bernhard Maisch,Michael Schoppet	13
7	Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac‐1 integrin 2006 ·The FASEB Journal ·(unknown),Valeria V. Orlova,Nadia Al‐Fakhri,Eveliina Ihanus,Matina Economopoulou,Berend Isermann,Khalil Bdeir,Peter P. Nawroth,Klaus T. Preissner,Carl G. Gahmberg,Marlys L. Koschinsky,Triantafyllos Chavakis	119
8	Osteoprotegerin expression in dendritic cells increases with maturation and is NF‐κB‐dependent 2006 ·Journal of Cellular Biochemistry ·Michael Schoppet,(unknown),Volker Ruppert,Thomas Stübig,Nadia Al‐Fakhri,Bernhard Maisch,Lorenz C. Hofbauer	32
9	TNF-related apoptosis-inducing ligand and its decoy receptor osteoprotegerin in nonischemic dilated cardiomyopathy 2005 ·Biochemical and Biophysical Research Communications ·Michael Schoppet,Volker Ruppert,Lorenz C. Hofbauer,(unknown),Nadia Al‐Fakhri,Michael Christ,Sabine Pankuweit,Bernhard Maisch	23
10	Expression of bone-regulating factors osteoprotegerin (OPG) and receptor activator of NF-κB ligand (RANKL) in heterotopic vascular ossification 2005 ·Thrombosis and Haemostasis ·Nadia Al‐Fakhri,Lorenz C. Hofbauer,Klaus T. Preissner,Folker E. Franke,Michael Schoppet	5
11	The role of junctional adhesion molecule‐C (JAM‐C) in oxidized LDL‐mediated leukocyte recruitment 2005 ·The FASEB Journal ·Tanja Keiper,Nadia Al‐Fakhri,Emmanouil Chavakis,Αθανάσιος Αθανασόπουλος,Berend Isermann,Stefanie Herzog,Rainer Saffrich,Karin Hersemeyer,Rainer M. Bohle,Judith Haendeler,Klaus T. Preissner,Sentot Santoso,Triantafyllos Chavakis	72
12	Factor VII activating protease (FSAP) inhibits growth factor‐mediated cell proliferation and migration of vascular smooth muscle cells. 2004 ·The FASEB Journal ·Christian Kannemeier,Nadia Al‐Fakhri,Klaus T. Preissner,Sandip M. Kanse	50
13	Localization of Osteoprotegerin, Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand, and Receptor Activator of Nuclear Factor-κB Ligand in Monckeberg’s Sclerosis and Atherosclerosis 2004 ·The Journal of Clinical Endocrinology & Metabolism ·Michael Schoppet,Nadia Al‐Fakhri,Folker E. Franke,Norbert Katz,Peter Barth,Bernhard Maisch,Klaus T. Preissner,Lorenz C. Hofbauer	155
14	The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins 2003 ·The Journal of Experimental Medicine ·Triantafyllos Chavakis,Angelika Bierhaus,Nadia Al‐Fakhri,Darius Schneider,Steffen Witte,Thomas Linn,Mariko Nagashima,John Morser,Bernd Arnold,Klaus T. Preissner,Peter P. Nawroth	489
15	Induction of Apoptosis in Vascular Cells by Plasminogen Activator Inhibitor-1 and High Molecular Weight Kininogen Correlates with Their Anti-Adhesive Properties 2003 ·Biological Chemistry ·Nadia Al‐Fakhri,Triantafyllos Chavakis,(unknown),Bei Huang,Sanjay M. Cherian,Yuri V. Bobryshev,Reginald S. A. Lord,N. Katz,Klaus T. Preissner	50
16	Endothelin-1 and vasopressin plasma levels are not associated with the insertion/deletion polymorphism of the human angiotensin I-converting enzyme gene in patients with coronary artery disease 2003 ·Journal of Human Hypertension ·Nadia Al‐Fakhri,(unknown),Monika Philipp,Martin Heidt,F. Hehrlein,Andreas Gardemann,N. Katz	7
17	Increased expression of disintegrin‐metalloproteinases ADAM‐15 and ADAM‐9 following upregulation of integrins α5β1 and αvβ3 in atherosclerosis 2003 ·Journal of Cellular Biochemistry ·Nadia Al‐Fakhri,Jochen Wilhelm,Meinhard Hahn,Martin Heidt,F. Hehrlein,(unknown),T. Hupp,Sanjay M. Cherian,Yuri V. Bobryshev,Reginald S. A. Lord,Norbert Katz	49
18	Molecular Interactions and Functional Interference between Vitronectin and Transforming Growth Factor-β 2002 ·Laboratory Investigation ·Michael Schoppet,Triantafyllos Chavakis,Nadia Al‐Fakhri,Sandip M. Kanse,Klaus T. Preissner	45
19	Insulin and local growth factor PDGF induce intimal hyperplasia in bypass graft culture models of saphenous vein and internal mammary artery 2002 ·European Journal of Cardio-Thoracic Surgery ·Bei Huang,Thomas Dreyer,Martin Heidt,(unknown),Monika Philipp,F. Hehrlein,Norbert Katz,Nadia Al‐Fakhri	31
20	Activity of acetylcholinesterase and unspecific cholinesterase during differentiation of somites in mouse embryos 1995 ·Anatomy and Embryology ·Nadia Al‐Fakhri,G. Bogusch	2

About Nadia Al‐Fakhri

Nadia Al‐Fakhri is a scholar working on Immunology and Allergy, Hematology and Cancer Research, having authored 26 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (10 papers), Protease and Inhibitor Mechanisms (5 papers) and Bone Metabolism and Diseases (5 papers). The work is most often cited by research in Clinical Biochemistry (349 citations), Immunology and Allergy (212 citations) and Immunology (344 citations). Nadia Al‐Fakhri has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Klaus T. Preissner, Triantafyllos Chavakis, Peter P. Nawroth, Michael Schoppet, John Morser, Thomas Linn, Mariko Nagashima, Steffen Witte, Darius Schneider and Bernd Arnold. Their work appears in journals such as The Journal of Experimental Medicine, The Journal of Immunology and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact